에 대한 최신 뉴스 Boston Beer Co (NYSE:SAM) 주식

Boston Beer Co

Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.

Movers

보스턴 비어 컴퍼니(NYSE:SAM)의 주가는 회사가 가장 잘 알려진 맥주 주식들 중 하나에 큰 변화가 될 수 있는 움직임으로 매각을 앞두고 있다는 보도로 금요일 급등했다. 어떤 일이 있었나 (What Happened): 보스턴 비어는 현재 30억 달러의 시가총액에 프리미엄을 추가한 매각에 가까워질 수 있다. 월스트리트 저널(WSJ)의 보도에 따르면 보스턴 비어는 짐빔(Jim Beam)의 소유주인 산토리(Suntory)와 협상 중이다.

샘 아담스, 트룰리 하드 셀처 등을 보유한 보스턴 비어의 매각 협상 보도로 주가 급등

Analyst Color

Equities

News

Upgrades

Price Target

Reiteration

Analyst Ratings

Trading Ideas

General

골드만삭스(Goldman Sachs)의 분석가 본니 헤르조그(Bonnie Herzog)는 최근 베버리지 바이트(Beverage Bytes)의 설문조사에서 맥주 유통업체들로부터 얻은 피드백을 바탕으로 몰슨 쿠어스 베버리지(NYSE:TAP)와 콘스텔레이션 브랜드(Constellation Brands Inc) (NYSE:STZ)에 대한 판단을 좀 더 긍정적이고, 보스톤 비어 컴퍼니(NYSE:SAM)에 대한 판단을 부정적으로 바꿨다.

골드만삭스는 몰슨 쿠어스와 컨스텔레이션 브랜드에 대해 더 긍정적 견해: 이유는?

Boston Beer Company, Inc. (The) Common Stock

Boston Beer Co Inc

Silvercrest Asset Management Group Inc. - Common Stock

Silvercrest Asset Management Group Inc

SANDVIK MATLS TECH HLDG by SANDVIK MATLS TECHNOLOGY HLDG AB

Alleima AB

SAMSARA LUGGAGE INC by Samsara Luggage, Inc.

Samsara Luggage Inc

The Advisors' Inner Circle Fund III Strategas Macro Momentum ETF

Sama Resources Inc

Samoyedcoin

The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF

The Boston Beer Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>) has retained its niche in the market, driven by its progress on its Beyond Beer strategy, the premiumization of the beer industry and robust trends for its twisted tea brand. Additionally, the company&#39;s innovation, intensified attention to pricing and product portfolio expansion efforts bode well. 
SAM is on track with the expansion of its Beyond Beer category, which includes exploring categories other than beer. Beyond Beer is growing faster than the traditional beer market, and the company expects this trend to continue for several years. SAM&#39;s advancement in the non-beer categories, including ciders and hard seltzer, as well as brand-building efforts, is expected to fortify its position in the market. 
Boston Beer is on track with growth of its Beyond Beer category, wherein it currently holds the second position. The company expects the trend to continue for the next several years. 
However, weak depletions, along with continued challenges in the hard seltzer category, acted as deterrents. The slowed consumer demand for hard seltzers has been hurting the company&#39;s performance, with marked declines noted for the Truly brand in recent quarters. 
Consequently, shares of the Zacks Rank #3 (Hold) company have lost 17.2% in the year-to-date period compared with the industry&#39;s decline of 11.5%. SAM also compared unfavorably with the Consumer Staples sector&#39;s growth of 0.7% and the S&amp;P 500&#39;s improvement of 7.6% in a year.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/5b/68839.jpg?v=1409913459" /> 
Image Source: Zacks Investment Research
<h3>Other Strategies in Focus</h3>
Boston Beer&#39;s pricing, product innovation and growth of non-beer categories alongside brand development efforts bode well. The company has been benefiting from strong price realization and procurement savings, which more than offset increased inflationary costs. 
SAM&#39;s focus on innovation to revive the Truly brand and expand Twisted Tea&#39;s potential bodes well. Boston Beer is keen on bringing excitement to the Truly brand&#39;s core flavors through innovation. The firm expects to improve the Truly brand&#39;s trends through a renewed focus on core business, smart brand innovation, and strong distributor support and retail execution. The company&#39;s Truly flavored bottle Vodka and Truly Vodka Seltzer have been performing well. 
Twisted Tea is the brand that drove most growth for Boston Beer in first-quarter 2024. Being one of the fastest-growing brands, Twisted Tea rose in the double-digits. Improved geographic, channel and package distribution; effective brand-building campaigns; increased media investment; and optimized packaging design have been aiding the performance of the Twisted Tea brand. 
The growing awareness of the Twisted Tea brand and household penetration also bode well. The company further expanded its light portfolio offerings with a new variety pack available in select highly developed markets and has received positive feedback for the same. 
In recent years, Boston Beer has implemented strategic pricing actions that have boosted its position in the competitive landscape. Craft beer enthusiasts are known for their willingness to pay a premium for unique and high-quality brews. SAM has leveraged this consumer mindset by strategically pricing its products to reflect the craft beer experience it offers. 
The company is optimistic about continued pricing gains in the near term. It estimates price increases of 1-2% for 2024.
<h3>Major Setbacks</h3>
Boston Beer&#39;s first-quarter 2024 results reflected continued softness in depletions and challenges in the hard seltzer category. The hard seltzer category&#39;s decelerating trend has mainly been attributed to the loss of novelty among consumers due to the entry of several beyond beer products in the marketplace. The decline has also resulted from the ongoing dismal macroeconomic environment, which has caused a volume shift from hard seltzers to premium light beers due to their lower pricing. The slowed hard seltzer sales continued to impact the company&#39;s Truly hard seltzer performance. 
In 2024, the hard-seltzer category is likely to remain under pressure and management anticipates category volume declines in the low teens. Depletions and shipments are expected between a low-single-digit decline and a low-single-digit increase for 2024.
<h3>Key Picks</h3>
We have highlighted three better-ranked stocks from the Consumer Staple sector, namely The Vita Coco Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coco#NASDAQ">COCO</a>), Vital Farms (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vitl#NASDAQ">VITL</a>) and PepsiCo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pep#NASDAQ">PEP</a>). 
Vita Coco, a producer and marketer of coconut water products under the Vita Coco brand name, currently flaunts a Zacks Rank of 1 (Strong Buy). COCO has a trailing four-quarter earnings surprise of 25.3%, on average. 
The Zacks Consensus Estimate for COCO&#39;s current financial-year sales and earnings suggests growth of 3.5% and 40.5%, respectively, from the year-ago reported figures. 
Vital Farms offers a range of produced pasture-raised foods. VITL presently sports a Zacks Rank of 1. It has a trailing four-quarter earnings surprise of 102.1%, on average. 
The consensus estimate for Vital Farms&#39; current financial year&#39;s sales and earnings per share indicates growth of 22.5% and 59.3%, respectively, from the year-ago reported figures. 
PepsiCo, a leading global food and beverage company, currently carries a Zacks Rank #2 (Buy). PEP has a trailing four-quarter earnings surprise of 5.1%, on average. 
The Zacks Consensus Estimate for PEP&#39;s current financial-year sales and earnings indicates growth of 3.4% and 7.1%, respectively, from the year-earlier actuals.
<a href="https://www.zacks.com/stock/news/2288642/can-boston-beer-s-sam-beyond-beer-expansion-aid-growth?cid=CS-BENZ-FT-analyst_blog|rank_focused-2288642">To read this article on Zacks.com click here.</a>

Earnings

Small Cap

Markets

COCO

VITL

Can Boston Beer's Beyond Beer Expansion Aid Growth?

Green Thumb Industries (OTC: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTC">GTBIF</a>) has expressed interest in merging with Boston Beer (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>), according to a recent report by Pablo Zuanic of Zuanic &amp; Associates. What strategic advantages does this merger offer? How will this impact the profitability of both companies? Could this merger set a precedent for future deals in the cannabis and beverage industries?
Zuanic&rsquo;s report presents the implications for investors of this potential merger, as it could reshape the <a href="https://www.benzinga.com/topic/cannabis-beverages">cannabis and beverage sectors</a>.
<h3>$3 Billion In Proforma 2023 Revenues</h3>
Boston Beer shares rose by 30% following a report of Suntory (OTC: <a class="ticker" href="https://www.benzinga.com/stock/stbfy#OTC">STBFY</a>) being in talks to <a href="https://www.benzinga.com/markets/cannabis/24/06/39170559/chicago-cannabis-company-green-thumb-proposes-merger-with-boston-beer-eyes-stock-listing">acquire the company</a>. On June 4th, a letter from Green Thumb CEO Ben Kovler to Boston Beer chairman Jim Koch was revealed, expressing interest in a merger. According to the report, despite Green Thumb issuing a statement refusing to comment on market rumors, the details suggest this is more than mere speculation.
A <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39196475/why-financial-firm-jefferies-sees-value-in-green-thumb-boston-beer-merger">merger between Green Thumb and Boston Beer </a>would create a company with $3 billion in proforma 2023 revenues, with two-thirds from SAM.
Zuanic&rsquo;s report explains SAM&#39;s revenues are projected to increase by 2% in 2024, while Green Thumb&#39;s are expected to grow by 15%. Despite higher sales, SAM operates in a flat to declining industry, whereas Green Thumb is in a growth sector.
Green Thumb&#39;s 31% adjusted EBITDA margin in 2023 surpasses SAM&#39;s 10.5%, highlighting the cannabis company&#39;s profitability.
&quot;While SAM sales are 2x those of Green Thumb, the latter is more profitable. Adjusted EBITDA margins at GTBIF in CY23 were 31% ($326Mn) vs. 10.5% for SAM ($210Mn), with reported gross margins of 50% vs. 42%, respectively. Reported EBIT margins at SAM were 10.5% in 2023 and 17.5% at Green Thumb. For proforma calculations we would estimate at most 3% cost synergies (some back-office functions and corporate overheads), as there is not much overlap,&quot; reads the report.&nbsp;
<h3>Financial Considerations</h3>
Financially, Green Thumb&#39;s<a href="https://www.benzinga.com/markets/cannabis/24/05/38716589/green-thumb-industries-revenue-increases-11-in-q1-2024-were-off-to-a-great-start-says-pres"> net debt</a> stood at $147 million at the end of 2023, with a manageable <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38805354/analysts-may-need-to-revise-cannabis-stock-projections-for-2024-10-companies-surpas">0.5x EBITDA</a>, while SAM had $298 million in cash and no financial debt.
According to Zuanic, a&nbsp;cash offer for SAM would significantly increase Green Thumb&#39;s leverage, making it an unlikely scenario. An <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38656307/big-players-in-u-s-cannabis-could-play-the-stock-value-card-in-m-a-new-report-shows">equity-based offer</a>, either 50/50 or 100%, would be more feasible and beneficial for both parties.
<h3>Strategic Benefits And Industry Impact</h3>
The merger would provide SAM with a platform for growth and profitability, while Green Thumb would gain<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39076254/top-ohio-cannabis-companies-analyst-look-at-stocks-with-potential-market-cap-gains"> strategic advantages</a>, including an indirect NASDAQ listing.
Current trading multiples show SAM at 1.3x forward sales and 10.3x EBITDA, compared to Green Thumb at 2.8x and 9x, respectively.
This potential merger could trigger other <a href="https://www.benzinga.com/general/biotech/23/03/31227249/from-controversial-to-profitable-why-nestl-procter-gamble-pepsico-and-other-cpg-brands-should-emb">consumer packaged goods companies</a> to explore opportunities in the cannabis sector.
The move aligns with the strategies of companies like Canopy Growth (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) and Tilray (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>), which have made similar moves.
With <a href="https://www.benzinga.com/markets/cannabis/24/05/38881456/bidens-greenlight-what-to-know-about-fed-regulated-marijuana-markets-legal-circuits-and-complian">federal rescheduling </a>of cannabis <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38905962/cannabis-rescheduling-when-will-it-happen-expert-lays-out-timeline-risks-and-wild-c">likely before January 2025</a>, this could be a critical window for such <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38969916/514m-tax-breaks-await-this-marijuana-company-with-rescheduling-market-cap-set-to-so">mergers and acquisitions</a>.
Learn more about leading cannabis companies and stocks, at&nbsp;the&nbsp;<a href="https://cannabismarketspotlight.com/" rel="noopener noreferrer" target="_blank">Benzinga Cannabis Market Spotlight</a>&nbsp;in New Jersey on June 17th! Grow your business, raise money, and capitalize on the booming NJ recreational market. Don&rsquo;t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left.&nbsp;<a href="https://www.eventbrite.com/e/benzinga-market-spotlight-new-jersey-cannabis-registration-871406729987?discount=JAVIER20" rel="noopener noreferrer" target="_blank">Use the code &quot;JAVIER20&quot; for 20% off!</a>
Photo: AI-Generated Image.&nbsp;

Cannabis

Mid Cap

Penny Stocks

Rumors

Contracts

Asset Sales

GTBIF

STBFY

TLRY

Rumors Of Green Thumb And Boston Beer Merger: What Investors Need to Know, Analyst Breaks It Down

7 analysts have shared their evaluations of Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $309.0, a high estimate of $360.00, and a low estimate of $250.00. Surpassing the previous average price target of $308.40, the current average has increased by 0.19%.
<img src="https://www.benzinga.com/files/images/story/2024/1717592437_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Boston Beer Co. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Sheridan</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$290.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$360.00</td>
<td>$335.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$273.00</td>
<td>-</td>
</tr>
<tr>
<td>Eric Serotta</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$325.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$315.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Bonnie Herzog</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$250.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$350.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Boston Beer Co. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Boston Beer Co's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Boston Beer Co's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Delving into Boston Beer Co's Background</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the US.
<h3>A Deep Dive into Boston Beer Co's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Boston Beer Co displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 3.92%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Boston Beer Co's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 2.96%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.19%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Boston Beer Co's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.9%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Boston Beer Co's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Boston Beer Co Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Morgan Stanley analyst Eric Sheridan upgrades Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) from Underweight to Equal-Weight and maintains the price target from $290 to $290.

Morgan Stanley Upgrades Boston Beer Co to Equal-Weight, Maintains Price Target to $290

Chicago-based <a href="http://benzinga.com/cannabis" target="_blank" rel="noreferrer noopener">cannabis</a> producer Green Thumb Industries (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>) has raised eyebrows throughout the beverage and weed industries with a recent proposal to merge with Boston Beer Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>), the iconic American brewer behind Sam Adams lager.
<h3 class="wp-block-heading">Green Thumb Seeks Stock Exchange Listing</h3>
Green Thumb&#8217;s primary motivation for the move appears to be gaining access to a major U.S. exchange. The Wall Street Journal <a href="https://www.wsj.com/business/cannabis-producer-seeks-boston-beer-merger-b89e43c7" target="_blank" rel="noreferrer noopener">reports</a> that Green Thumb CEO Ben Kovler outlined this central objective in a letter to Boston Beer founder and chairman Jim Koch, as well as other potential benefits for both companies. 
A successful merger would allow Green Thumb, currently listed on a Canadian exchange and over-the-counter in the U.S., to finally gain access to a prestigious exchange like the New York Stock Exchange (NYSE). News about the letter sent Boston Beer&#8217;s stock price soaring over 20% last Friday, noted the WSJ.
However, despite <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38905962/cannabis-rescheduling-when-will-it-happen-expert-lays-out-timeline-risks-and-wild-c" target="_blank" rel="noreferrer noopener">cannabis rescheduling moving forward</a>, federal restrictions still prevent companies in the sector from directly listing on such major exchanges.
<h3 class="wp-block-heading">Product Innovation And Market Power</h3>
Beyond exchange access, Kovler's letter also envisioned a combined entity positioned to develop innovative cannabis-infused products like <a href="https://www.benzinga.com/topic/edibles" target="_blank" rel="noreferrer noopener">edibles</a>, <a href="https://www.benzinga.com/topic/cannabis-beverages" target="_blank" rel="noreferrer noopener">drinks</a> and <a href="https://www.benzinga.com/markets/cannabis/24/03/37949190/after-the-pre-roll-boom-whats-next-in-cannabis-products-the-secret-is-under-the-microscope" target="_blank" rel="noreferrer noopener">pre-rolled</a> joints. Additionally, he said the merger could create a more powerful industry player with greater clout in mergers and acquisitions.
<h3 class="wp-block-heading">Shifting Consumer Preferences And Rise Of THC Beverages</h3>
Interestingly, Boston Beer already dipped it toe into the cannabis market with its <a href="https://www.benzinga.com/markets/cannabis/22/05/27344695/the-boston-beer-company-introduces-teapot-a-new-line-of-cannabis-infused-iced-teas" target="_blank" rel="noreferrer noopener">TeaPot brand of cannabis-infused iced tea</a>, which is available in <a href="http://benzinga.com/topic/canada-cannabis" target="_blank" rel="noreferrer noopener">Canada</a>. But this wouldn&#8217;t be the first cannabis-alcohol industry tie-up. Last year, Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) <a href="https://www.benzinga.com/markets/cannabis/23/10/35031971/tilray-completes-acquisition-of-8-beer-brands-from-bud-light-parent-anheuser-busch" target="_blank" rel="noreferrer noopener">acquired 8 craft beer brands</a> from Bud Light&#8217;s parent company Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>). In a recent panel discussion at the Benzinga Cannabis Capital Conference in Florida, industry experts noted that <a href="https://www.benzinga.com/markets/cannabis/24/05/38566712/are-hemp-thc-beverages-competing-with-alcohol-experts-discuss-new-alternatives-for-adult-beverag" target="_blank" rel="noreferrer noopener">THC-infused beverages could soon potentially outsel traditional staples like wine and vodka</a>.  
Nevertheless, while Boston Beer&#8217;s own THC <a href="https://www.benzinga.com/markets/cannabis/24/04/38468600/sam-adams-says-hold-my-beer-and-you-are-sales-numbers-dispute-cannabis-cannibalization-narrative" target="_blank" rel="noreferrer noopener">TeaPot hasn&#8217;t cannibalized sales of its core brands</a>, the proposed merger has reignited discussions about the potential convergence of the cannabis and alcohol industries.
Read also: <a href="https://www.benzinga.com/markets/cannabis/24/05/39046889/dea-rules-thca-is-not-legal-hemp-amid-industry-shake-up-and-farm-bill-debate-on-delta-8-thc-proh" target="_blank" rel="noreferrer noopener">DEA Rules THCA Is Not Legal Hemp Amid Industry Shake-Up And Farm Bill Debate On Delta-8 THC Prohibition</a>
Photo: Courtesy of Engin Akyurt and Washarapol D BinYo Jundang by Pexels and Linkedin.

Chicago Cannabis Company Green Thumb Proposes Merger With Boston Beer, Eyes Stock Listing

<a href="https://www.globenewswire.com/news-release/2024/06/04/2893189/0/en/Green-Thumb-Industries-Responds-to-Market-Rumors.html" title="https://www.globenewswire.com/news-release/2024/06/04/2893189/0/en/Green-Thumb-Industries-Responds-to-Market-Rumors.html">https://www.globenewswire.com/news-release/2024/06/04/2893189/0/en/Green-Thumb-Industries-Responds-to-Market-Rumors.html</a>

Green Thumb Industries Responds To Media Speculation; States Policy Is Not To Comment On Market Rumors

<a href="https://www.wsj.com/business/cannabis-producer-seeks-boston-beer-merger-b89e43c7?mod=latest_headlines" title="https://www.wsj.com/business/cannabis-producer-seeks-boston-beer-merger-b89e43c7?mod=latest_headlines">https://www.wsj.com/business/cannabis-producer-seeks-boston-beer-merger-b89e43c7?mod=latest_headlines</a>

'Cannabis Producer Seeks Boston Beer Merger' - WSJ

Shares of Science Applications International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) declined 11% to $119.91 following <a href="https://www.benzinga.com/news/earnings/24/06/39136938/science-applications-international-optimistic-about-hitting-annual-outlook-despite-q1-revenue-dip-s">first-quarter results.</a>
SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
SAIC shares dipped 11% to $119.91 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Microbot Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBOT#NASDAQ">MBOT</a>) jumped 92.5% to $1.9301 after the company received FDA approval to proceed with its pivotal human clinical trial.</li>
<li>Bio-Path Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares jumped 75% to $3.62. Bio-Path presented interim results from Phase 2 study of Prexigebersen (BP1001) in combination with decitabine and venetoclax for acute myeloid leukemia at the American Society Of Clinical Oncology Annual Meeting.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares climbed 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.</li>
<li>Professional Diversity Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) gained 28.5% to $0.65. Professional Diversity Network recently named Megan Bozzuto as interim CFO.</li>
<li>MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) gained 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) shares rose 27% to $0.1271 after dipping 12% on Friday.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) climbed 26.5% to $0.4425 after the company reported an agreement to acquire Oxylus Global.</li>
<li>Dogness (International) Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) gained 23.5% to $13.65</li>
<li>Affimed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) gained 22.2% to $5.25 as the company issued follow-up data of AFM24 plus atezolizumab showing durable responses in heavily pretreated NSCLC EGFR wild-type patients and positive initial data from the NSCLC EGFR mutant cohort.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) rose 17.6% to $0.5883.</li>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) rose 17.5% to $4.8001.</li>
<li>Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) gained 17.5% to $1.5282.</li>
<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) gained 16.8% to $15.03 as the company said District Court issued favorable ruling and denied United Therapeutics&#8217; request to block YUTREPIA&#x2122; launch.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) rose 15.5% to $11.18.</li>
<li>Stericycle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) gained 15% to $59.28 after the company announced that it entered into a definitive agreement to be acquired by Waste Management.</li>
<li>Precigen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) rose 15% to $1.61 after reporting study data for PRGN-2012 for recurrent respiratory papillomatosis patients.</li>
<li>Coherent Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NASDAQ">COHR</a>) gained 13.4% to $64.71 after the company announced the appointment of Jim Anderson as CEO.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) rose 11.8% to $36.34</li>
<li>Structure Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) rose 11.8% to $38.25 after the company reported 12-week results for obesity drug GSBR-1290, achieving significant weight loss.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) gained 11.6% to $4.8330. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 10.7% to $16.65.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) rose 9% to $21.67 as the company agreed to sell its wholly owned subsidiaries OneNeck IT Solutions and OneNeck Data Center to US Signal Company, LLC.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares gained 8.8% to $0.6348 after gaining over 3% on Friday. </li>
<li>Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) gained 8.3% to $218.39 after the company issued preliminary results and said there will be no restatement or adjustment of any audited or unaudited financial statements.</li>
<li>Molecular Partners AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) shares climbed 8.2% to $4.0699. Molecular Partners presented data from completed Phase 1 trial of MP0317 monotherapy in advanced solid tumors at ASCO 2024.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>CalAmp Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) shares fell 61.4% to $1.03 after the company said it has entered into a Restructuring Support Agreement with its principal secured lender, Lynrock Lake Master Fund LP, who will become the principal equity owner of CalAmp and take the Company private.</li>
<li>Ault Disruptive Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADRT#NASDAQ">ADRT</a>) fell 52.2% to $21.50.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) fell 32.3% to $0.1463. CNS Pharmaceuticals announced a 1-for-50 reverse stock split.</li>
<li>Galera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) fell 30% to $0.1536. Galera Therapeutics will be delisted by Nasdaq.</li>
<li>Portage Biotech Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares fell 29.7% to $0.3365 after gaining over 91% on Friday.</li>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) dipped 29.5% to $0.7895.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) fell 26.3% to $0.3501.</li>
<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) shares declined 24.4% to $0.3251.</li>
<li>Webuy Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) fell 23.7% to $0.1870.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) fell 21.2% to $2.67.</li>
<li>Vintage Wine Estates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWE#NASDAQ">VWE</a>) fell 19.2% to $0.2883.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) fell 19.2% to $105.00</li>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares fell 16.4% to $4.55 after jumping over 110% on Friday.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) fell 15.1% to $63.00 after the company announced an interim CEO following Jim Anderson&#8217;s decision to step down as President, CEO and Board member to pursue an opportunity with another company.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) dipped 13.8% to $112.00.</li>
<li>Digital Health Acquisition Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAC#NASDAQ">DHAC</a>) shares fell 10.3% to $15.25 after gaining 13% on Friday.</li>
<li>Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMAB#NASDAQ">OMAB</a>) declined 10.2% to $73.44.</li>
<li>Immunocore Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) fell 10.1% to $44.05.</li>
<li>Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAC#NYSE">PAC</a>) fell 10% to $169.23.</li>
<li>GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) fell 8.7% to $40.87 after the company said it will appeal a ruling made by the Delaware State Court regarding its ongoing ranitidine litigation.</li>
<li>The Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) declined 7.7% to $64.33.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) fell 7.7% to $20.81.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) fell 7.1% to $129.63. On May 30, Dell reported upbeat earnings and sales results for the first quarter.</li>
<li>Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) dipped 6.5% to $92.61.</li>
</ul>
The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4.7% to $299.07. Boston Beer shares jumped around 22% on Friday following a report suggesting the company is in talks to sell itself to Suntory. Boston Beer later issued a statement on the company sale speculation. "We are fully focused on our business as an independent company and our return to growth," the company said.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39137769/this-mongodb-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-monday">This MongoDB Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday</a>

Intraday Update

ADRT

ADSK

AFMD

BNAI

BPTH

CAMP

CGON

CNSP

COHR

CRKN

DELL

DHAC

DOGZ

DRCT

EFSH

FFIE

FOXO

GPCR

GRTX

IMCR

IPDN

ISPC

LQDA

LSCC

MBOT

MGNX

MOLN

NVAX

OLMA

Grupo Aeroportuario del Centro NorteB de CV

OMAB

PGEN

PRTG

PSNL

SAIC

SRCL

Vintage Wine Estates, Inc. - Common Stock

WBUY

YGMZ

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.5% on Monday.
Shares of GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) fell sharply in today's pre-market trading after the company said it will appeal a ruling made by the Delaware State Court regarding its <a href="https://www.benzinga.com/quote/GSK/analyst-ratings">ongoing ranitidine litigation</a>.
GSK shares tumbled 9.2% to $40.66 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 9.5% to $ 284.04 in pre-market trading. Boston Beer shares jumped around 22% on Friday following a report suggesting the company is in talks to sell itself to Suntory. Boston Beer later issued a statement on the company sale speculation. "We are fully focused on our business as an independent company and our return to growth," the company said.</li>
<li>Anavex Life Sciences Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) shares declined 8.9% to $3.70 in pre-market trading. Anavex Life Sciences recently announced expansion of leadership team.</li>
<li>Sezzle Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) shares declined 5.6% to $75.66 in pre-market trading.</li>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) shares fell 5.5% to $20.83 in pre-market trading.</li>
<li>OneWater Marine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) shares fell 5.2% to $24.50 in pre-market trading. Bloomberg reported Sunday that OneWater is in talks to buy MarineMax for $40 per share. OneWater Marine responded to market reports, saying, &#8220;As a matter of policy, we do not comment on market rumors or speculation.&#8221;</li>
<li>Murano Global Investments Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNO#NASDAQ">MRNO</a>) shares declined 4.4% to $10.28 in pre-market trading after falling around 9% on Friday.</li>
<li>Compass Pathways PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) shares fell 3.7% to $7.10 in pre-market trading.</li>
<li>BW LPG Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWLP#NYSE">BWLP</a>) shares slipped 3.4% to $21.19 in pre-market trading. The company, last week, reported results for its first quarter and declared a quarterly cash dividend of $1.00/share.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/06/39130379/science-applications-international-autodesk-and-3-stocks-to-watch-heading-into-monday">Science Applications International, Autodesk And 3 Stocks To Watch Heading Into Monday</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

Pre-Market Outlook

AVXL

BWLP

CMPS

MRNO

ONEW

SAVA

SEZL

GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Boston Beer Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares soared Friday with a report the company is nearing a sale in a move that could be a big change for one of <a href="https://www.benzinga.com/topic/beer-stocks">best-known beer stocks.</a>
 What Happened: Boston Beer could be nearing a sale that would value the company at a premium to its current $3 billion market capitalization. &nbsp;
A Wall Street Journal <a href="https://www.wsj.com/business/deals/boston-beer-in-talks-to-sell-itself-to-jim-beam-owner-suntory-d0f23485?page=1">report </a>said Boston Beer is in talks with Suntory, the owner of Jim Beam. &nbsp;
Boston Beer owns the flagship Samuel Adams beer brand and owner of Twisted Tea Hard Iced Tea, Angry Orchard Hard Cider, Dogfish Head beer, Truly Hard Seltzer and several other brands.
The company was founded by Jim Koch in 1984. Koch is the chairman of the company and holds 100% of the voting rights via Class B shares, which makes his approval of a deal necessary.
Boston Beer CEO Dave Burwick retired in April.
Related Link: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38827272/boston-beer-company-gets-a-spicy-buy-upgrade-from-analyst-amid-other-beer-brands-re">Boston Beer Company Gets A Spicy Buy Upgrade From Analyst Amid Other Beer Brands &#8211; Read Why</a>
Why It's Important: Suntory is the owner of Jim Beam and Maker's Mark and several beer, spirits and wine brands. The company is also a bottler of PepsiCo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NYSE">PEP</a>) brands in several international markets like Japan and Vietnam. Suntory paid $13.6 billion for Beam in 2014.
Boston Beer and Suntory signed a partnership for ready-to-drink beverages in 2021.
The potential acquisition comes with Boston Beer shares down around 25% on the year and as several beer companies have declared bankruptcy.
The company saw its shares soar when Truly Hard Seltzer<a href="https://www.benzinga.com/news/22/07/28158761/if-you-invested-1-000-in-boston-beer-stock-when-truly-hard-seltzer-was-launched-heres-how-much-youd"> was launched</a> and hard seltzers saw a boom for several years. &nbsp;
 SAM Price Action: Boston Beer shares are up 21.52% to $311.58 on publication Friday. Shares were briefly halted as the report led to a price spike.
Read Next: <a href="https://www.benzinga.com/quote/SAM/analyst-ratings">Analyst Ratings For The Boston Beer Company </a>
 The average American couple has saved this much money for retirement —&nbsp;<a href="http://www.benzinga.com/money/smartasset" target="_blank" rel="noreferrer noopener">How do you compare</a>?
Photo: Shutterstock

Sam Adams, Truly Hard Seltzer Owner Boston Beer In Talks To Sell: What Investors Need To Know

The Boston Beer Company Shares Resume Trade

WIIM

Boston Beer shares are trading higher following a report suggesting the company is in talks to sell itself to Suntory.

The Boston Beer Company Shares Halted On Circuit Breaker To The Upside, Stock Now Up 6.14%

<a href="https://www.wsj.com/business/deals/boston-beer-in-talks-to-sell-itself-to-jim-beam-owner-suntory-d0f23485?page=1">https://www.wsj.com/business/deals/boston-beer-in-talks-to-sell-itself-to-jim-beam-owner-suntory-d0f23485?page=1</a>
&nbsp;

'Boston Beer In Talks To Sell Itself To Jim Beam Owner Suntory; Deal For Samuel Adams Owner, Which Has A Market Value Around $3B, Is In Early Stages'

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>)</h3>
<ul>
<li>On May 22, Molson Coors Beverage Company announced the pricing of its public offering of euro-denominated senior notes. The company's stock fell around 7% over the past month and has a <a href="https://www.benzinga.com/quote/TAP">52-week low of $52.60</a>.</li>
<li>RSI Value: 23.78</li>
<li>TAP Price Action: Shares of Molson Coors Beverage gained 0.4% to close at $53.22 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://pro.benzinga.com/dashboard">latest TAP news</a>.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-1024x560.png" alt="" class="wp-image-364744" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM.png 1369w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">Adecoagro S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>)&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On May 16, Adecoagro posted better-than-expected quarterly sales. The company's stock fell around 10% over the past month. It <a href="ttps://www.benzinga.com/quote/AGRO">has a 52-week low</a> of $8.82.</li>
<li>RSI Value: 29.47</li>
<li>AGRO Price Action: Shares of Adecoagro gained 0.8% to close at $9.78 on Thursday.</li>
<li><a href="https://pro.benzinga.com/dashboard">Benzinga Pro's charting tool</a> helped identify the trend in Adecoagro's stock.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="536" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-1024x536.png" alt="" class="wp-image-364748" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-1024x536.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-768x402.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM.png 1380w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">The Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>)</h3>
<ul>
<li>On May 15, GoodRx Holdings announced a new direct contracting agreement with Kroger. The company's stock fell around 3% over the past five days and has a 52-week l<a href="https://www.benzinga.com/quote/KR">ow of $42.10.</a></li>
<li>RSI Value: 29.17</li>
<li>KR Price Action: Shares of Kroger rose 0.2% to close at $51.98 on Thursday.</li>
<li>Benzinga Pro's earnings calendar was used to track <a href="https://pro.benzinga.com/dashboard">Kroger's upcoming earnings report</a></li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-1024x561.png" alt="" class="wp-image-364749" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM.png 1378w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">The Boston Beer Company, Inc.. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>)</h3>
<ul>
<li>On April 25, Boston Beer reported better-than-expected first-quarter financial results and issued FY24 GAAP EPS guidance. &#8220;We were pleased to see flat depletion trends in the first quarter and to deliver revenue growth,&#8221; said Chairman and Founder Jim Koch. &#8220;We remain committed to investing across our portfolio of brands to drive long-term revenue growth while also expanding our margins.&#8221; The company's shares lost around 8% over the past month. The company's 52-week low is $254.40.</li>
<li>RSI Value: 29.37</li>
<li>SAM Price Action: Shares of Boston Beer rose 0.2% to close at $256.41 on Thursday.</li>
<li><a href="https://pro.benzinga.com/dashboard">Benzinga Pro's signals feature</a> notified of a potential breakout in Boston Beer shares.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-1024x577.png" alt="" class="wp-image-364751" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM.png 1370w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">Hormel Foods Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>)</h3>
<ul>
<li>On May 30, Hormel Foods reported second-quarter fiscal 2024 sales declined 3% year-over-year to $2.887 billion, missing the consensus of $2.967 billion. "To reflect our solid first-half performance and our expectations for continued growth from our Foodservice and International segments, ongoing improvements across our supply chain, and further benefits from our transform and modernize initiative, we are updating our full-year earnings outlook," stated Jim Snee, chairman of the board, president and chief executive officer. The company's shares fell around 13% over the past five days. The company <a href="https://www.benzinga.com/quote/HRL">has a 52-week low</a> of $28.51.</li>
<li>RSI Value: 22.95</li>
<li>HRL Price Action: Shares of Hormel Foods fell 9.7% to close at $30.79 on Thursday.</li>
<li><a href="https://pro.benzinga.com/dashboard">Insider trades for Hormel Foods</a> were monitored using Benzinga Pro.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="566" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-1024x566.png" alt="" class="wp-image-364752" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-1024x566.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-768x424.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM.png 1378w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read More: <a href="https://www.benzinga.com/news/earnings/24/05/39104172/dell-asana-and-3-stocks-to-watch-heading-into-friday">Dell, Asana And 3 Stocks To Watch Heading Into Friday</a>

Long Ideas

AGRO

Top 5 Defensive Stocks That May Explode This Quarter

Jefferies&nbsp;analyst Kaumil&nbsp;Gajrawala upgraded&nbsp;Boston Beer Company, Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) to Buy from Hold,&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/SAM/analyst-ratings" rel="noreferrer noopener">raising the price forecast to $360 from $335.</a>
Boston Beer has gone through several boom-bust cycles, but over time, value was created with higher highs and higher lows, the analyst writes.
The&nbsp;company&#8217;s beer and cider brands continue to decline, in line with the category. Collectively these brands are ~28%, Gajrawala notes.&nbsp;
However, reduced SKU complexity and refocused marketing could stabilize the business as category trends moderate. Given their relative size to Twisted/Truly, their headwinds should have minimal effect on total company trends&nbsp;going forward.
In addition, easing supply chain costs, higher in-house production, and efficiency measures support gross margin returning to normalized levels (high 40s %) over the medium term.&nbsp;
A clean balance sheet (no debt) and record cash levels increase the potential for capital returns if new initiatives do not gain traction, according to the analyst.
Per Gajrawala,&nbsp;with Truly trends stabilizing and Twisted continuing its recent growth trends, the company should return to volume growth for the first time since 2021.
Overall, the analyst raised the company&#8217;s full-year 2024 sales/EBITDA outlook by +1% and +3%,&nbsp;respectively.
The analyst applauds the company&#8217;s margin outlook and multiple expansions on&nbsp;return to volume&nbsp;growth and decreased volatility.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, SAM stock has lost 9% in the past year.&nbsp;
Gajrawala&nbsp;reiterated the Buy rating on&nbsp;Constellation Brands, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>), l<a target="_blank" href="https://www.benzinga.com/quote/STZ/analyst-ratings" rel="noreferrer noopener">owering&nbsp;the price target to $311 from $314.</a>
The analyst lowered the first quarter and FY25 sales outlook by -1% and &lt;-1% and EBITDA by -3% and -1%, respectively, given recent weakness.&nbsp;However, distributors remain bullish on Constellation. The analyst&#8217;s survey supports ~7%-9% org sales growth in their beer business.
Gajrawala reiterated&nbsp;Hold&nbsp;rating&nbsp;on&nbsp;Molson Coors Beverage Company&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>),&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/TAP/analyst-ratings" rel="noreferrer noopener">with&nbsp;forecast&nbsp;of&nbsp;$62.00.</a>
The analyst lowered CY24 sales &lt;-1% and EBITDA by -1%, given confirmed lower space gains, ABI momentum, and margin deleverage.
Price Action: TAP shares are trading lower by 1.45% to $57.89 at last check Tuesday, while STZ shares are trading lower by 2.2% to $253.07 and SAM shares are trading higher by 0.29% to $284.64.
Photo via Shutterstock

Boston Beer Company Gets A Spicy Buy Upgrade From Analyst Amid Other Beer Brands - Read Why

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Jefferies analyst Kaumil Gajrawala upgraded The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) from Hold to Buy and increased the price target from $335 to $360. Boston Beer shares declined 2.5% to close at $283.82 on Monday. <a href="https://www.benzinga.com/quote/SAM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan analyst Rahul Krotthapalli upgraded the rating on Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) from Neutral to Overweight, while boosting the price target from $68 to $78. Planet Fitness shares gained 0.9% to settle at $65.56 on Monday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Guggenheim analyst Debjit Chattopadhyay upgraded the rating for Amicus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) from Neutral to Buy and announced a $13 price target. Amicus Therapeutics shares fell 2.1% to settle at $9.04 on Monday. <a href="https://www.benzinga.com/quote/FOLD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird analyst Eric Coldwell upgraded Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) from Neutral to Outperform, but slashed the price target from $45 to $36.. Fortrea Holdings shares fell 14.9% to close at $28.11 on Monday. Fortrea reported soft first-quarter FY24 results and<a href="https://www.benzinga.com/pressreleases/24/05/g38783870/fortrea-reports-first-quarter-2024-results"> cut its revenue outlook</a> on Monday. <a href="https://www.benzinga.com/quote/FTRE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Neil Kalton upgraded Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) from Equal-Weight to Overweight, while raising the price target from $72 to $86. Edison Intl shares slipped 0.6% to settle at $74.44 on Monday. <a href="https://www.benzinga.com/quote/EIX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38814917/top-5-tech-and-telecom-stocks-which-could-rescue-your-portfolio-this-quarter">Top 5 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Quarter</a>

Downgrades

FOLD

FTRE

PLNT

This Boston Beer Analyst Turns Bullish; Here Are Top 5 Upgrades For Today.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Roth MKM cut the price target for Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) from $55 to $35. Roth MKM analyst Eric Handler downgraded the stock from Buy to Neutral. Roblox shares fell 1.6% to close at $30.96 on Monday. <a href="https://www.benzinga.com/quote/RBLX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham boosted the price target for Verrica Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) from $8 to $16. Needham analyst Serge Belanger maintained a Buy rating. Verrica Pharmaceuticals shares jumped 19.5% to close at $9.56 on Monday. <a href="https://www.benzinga.com/quote/VRCA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird cut Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) price target from $45 to $36. Baird analyst Eric Coldwell upgraded the stock from Neutral to Outperform. Fortrea shares fell 14.9% to close at $28.11 on Monday. <a href="https://www.benzinga.com/quote/FTRE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho boosted the price target for Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) from $15 to $17. Mizuho analyst Wei Fang maintained a Buy rating. Tencent Music shares jumped 10.9% to close at $14.80 on Monday. <a href="https://www.benzinga.com/quote/TME/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel increased AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) price target from $81 to $86. Stifel analyst Bert Subin maintained a Buy rating. AAR shares fell 0.6% to close at $71.75 on Monday. <a href="https://www.benzinga.com/quote/AIR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird boosted Everbridge, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVBG#NASDAQ">EVBG</a>) price target from $29 to $35. Baird analyst William Power maintained a Neutral rating. Everbridge shares fell 0.1% to close at $34.71 on Monday. <a href="https://www.benzinga.com/quote/EVBG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer raised the price target for Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) from $95 to $100. Oppenheimer analyst Brian Schwartz maintained an Outperform rating. Agilysys shares fell 2% to close at $80.21 on Monday. <a href="https://www.benzinga.com/quote/AGYS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan boosted Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) price target from $68 to $78. JP Morgan analyst Rahul Krotthapalli upgraded the stock from Neutral to Overweight. Planet Fitness shares rose 0.9% to close at $65.56 on Monday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies increased The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) price target from $335 to $360. Jefferies analyst Kaumil Gajrawala upgraded the stock from Hold to Buy. Boston Beer shares fell 2.5% to close at $283.82 on Monday. <a href="https://www.benzinga.com/quote/SAM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler raised Natera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) price target from $110 to $120. Piper Sandler analyst David Westenberg maintained an Overweight rating. Natera shares fell 1.9% to close at $103.33 on Monday. <a href="https://www.benzinga.com/quote/NTRA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38814917/top-5-tech-and-telecom-stocks-which-could-rescue-your-portfolio-this-quarter">Top 5 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Quarter</a>

AGYS

EVBG

NTRA

RBLX

VRCA

Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday

Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $320.64, a high estimate of $360.00, and a low estimate of $250.00. Experiencing a 2.29% decline, the current average is now lower than the previous average price target of $328.14. 
<img src="https://www.benzinga.com/files/images/story/2024/1715691640_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Boston Beer Co. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$360.00</td>
<td>$335.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$273.00</td>
<td>-</td>
</tr>
<tr>
<td>Eric Serotta</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$325.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$315.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Bonnie Herzog</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$250.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$350.00</td>
<td>-</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$350.00</td>
<td>$370.00</td>
</tr>
<tr>
<td>Sean King</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$355.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Boston Beer Co. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Boston Beer Co's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Boston Beer Co's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Discovering Boston Beer Co: A Closer Look</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.
<h3>A Deep Dive into Boston Beer Co's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Boston Beer Co showcased positive performance, achieving a revenue growth rate of 3.92% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 2.96%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Boston Beer Co's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.19%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.9%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Boston Beer Co's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 11 Analyst Projections For Boston Beer Co

Jefferies analyst Kaumil Gajrawala upgrades Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) from Hold to Buy and raises the price target from $335 to $360.

Jefferies Upgrades Boston Beer Co to Buy, Raises Price Target to $360

Suntory Holdings says it's not in discussions to buy Boston Beer - report

Filippo Falorni, an analyst from Citi, maintained the Hold rating on Boston Beer (SAM – Research Report). The associated price target was raised to...

Hold Rating for Boston Beer Amidst Takeover Talks and Operational Challenges

Boston Beer (SAM – Research Report), the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Nadine Sarwat fro...

Evaluating the Implications of a Potential Suntory Acquisition on Boston Beer's Hold Rating

Jefferies analyst Kaumil Gajrawala maintained a Buy rating on Boston Beer (SAM – Research Report) today and set a price target of $355.00. The comp...

Boston Beer (SAM) Receives a Buy from Jefferies

Boston Beers falls amid report Green Thumb Industries interested in merger

Boston Beer falls amid report Green Thumb Industries interested in merger

Analyst Filippo Falorni from Citi maintained a Hold rating on Boston Beer (SAM – Research Report) and keeping the price target at $325.00. Filippo ...

Boston Beer: Hold Rating Maintained Amidst M&A Speculation and Business Headwinds

Boston Beer likely to do deal with beer/spirits company over cannabis firm - analyst

Don't Reinvent The Wheel: First Half Portfolio Performance

Sizzling Prices: July 4th barbecue will cost more this year than any other

BNED

BZFD

CABGY

CALM

CAVA

CURI

FARM

HEINY

MESA

NATH

PLCE

ROKU

RRGB

Press Releases

SAMUEL ADAMS TAPPED AS THE OFFICIAL BEER AND NON-ALCOHOLIC BEER OF THE PAN-MASS CHALLENGE

Restaurants

Dogfish Head Craft Brewery Unveils New Beer Packaging Artwork & Announces the Return of its Fan-Favorite 120 Minute IPA

Dogfish Head Cocktails Expands Award-Winning Lineup of Spirits-Based, Ready-to-Drink Cocktails with New Strawberry Lime Tequila Margarita

Samuel Adams Introduces American Light: A Crisp, Refreshing, High-Quality Light Beer

Beverage Industry Leader Dave Burwick Joins The Duckhorn Portfolio Board of Directors

The Boston Beer Company Statement on Company Sale Speculation

Dogfish Head & Dan-O's Seasoning to Debut Limited-Edition Grilling Kit

SAMUEL ADAMS SELECTS CROWNS & HOPS BREWING CO. AS 2024 BREWING & BUSINESS EXPERIENCESHIP WINNER

TRULY® HARD SELTZER HEATS UP U.S. SOCCER PARTNERSHIP IN TIME FOR SUMMER KICK-OFF

TeaPot Launches Two New Summer Flavours

NAPA

Ambev S.A. American Depositary Shares (Each representing 1 Common Share)

Ambev

Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

Anheuser-Busch InBev

Compania Cervecerias Unidas, S.A. Common Stock

United Breweries Co

Molson Coors Beverage Company Class B Common Stock

Molson Coors Beverage

Morgan Stanley

Jefferies

Deutsche Bank

Evercore ISI Group

Citigroup

보스턴 비어 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>)의 주가는 회사가 <a href="https://www.benzinga.com/topic/beer-stocks">가장 잘 알려진 맥주 주식들</a> 중 하나에 큰 변화가 될 수 있는 움직임으로 매각을 앞두고 있다는 보도로 금요일 급등했다.
어떤 일이 있었나 (What Happened): 보스턴 비어는 현재 30억 달러의 시가총액에 프리미엄을 추가한 매각에 가까워질 수 있다.
월스트리트 저널(WSJ)의 <a href="https://www.wsj.com/business/deals/boston-beer-in-talks-to-sell-itself-to-jim-beam-owner-suntory-d0f23485?page=1">보도</a>에 따르면 보스턴 비어는 짐빔(Jim Beam)의 소유주인 산토리(Suntory)와 협상 중이다.
보스턴 비어는 대표적인 사무엘 아담스(Samuel Adams) 맥주 브랜드를 소유하고 있으며, 트위스티드 티 하드 아이스드 티(Twisted Tea Hard Iced Tea), 앵그리 오차드 하드 사이더(Angry Orchard Hard Cider), 도그피쉬 헤드(Dogfish Head) 맥주, 트룰리 하드 셀처(Truly Hard Seltzer) 및 기타 여러 브랜드의 소유자이다.
이 회사는 1984년 짐 코치(Jim Koch)에 의해 설립되었다. 코치는 이 회사의 회장이며 클래스 B 주식을 통해 100% 의결권을 보유하고 있으므로 거래 승인이 필요하다.
보스턴 비어의 CEO인 데이브 버윅(Dave Burwick)는 4월에 은퇴했다.
관련 링크: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38827272/boston-beer-company-gets-a-spicy-buy-upgrade-from-analyst-amid-other-beer-brands-re">다른 맥주 브랜드들과 관련해서 분석가들로부터 긍정적인 평가를 받은 보스턴 비어</a>
왜 중요한가 (Why It&#8217;s Important): 산토리는 짐 빔과 메이커스 마크(Maker&#8217;s Mark) 및 여러 맥주, 스프라이트 및 와인 브랜드의 소유권을 보유하고 있다. 이 회사는 또한 일본 및 베트남과 같이 여러 국제 시장에서 펩시코(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NYSE">PEP</a>)의 브랜드들을 병입하는 업체이다. 산토리는 2014년 빔 인수에 136억 달러를 지불했다.
보스턴 비어와 산토리는 2021년 즉석 음료에 대한 파트너십을 체결했다.
이번 인수 가능성은 보스턴 비어 주가가 전년 대비 약 25% 하락하고 여러 맥주 회사들이 파산을 선언한 가운데 이루어졌다.
이 회사는 트룰리 하드 셀처(Truly Hard Seltzer)가 출시되면서 주가가 급등했고, 하드 셀처(Hard Seltzer)는 몇 년 동안 호황을 누렸습니다.
SAM 주식의 움직임: 이 보도로 금요일 보스턴 비어의 주식은 정규장에서 이 보도로 인해 가격이 급등한 관계로 잠시 거래가 중단된 적이 있었다. 이 주식은 22.33% 급등한 313.67달러에 마감했다. 이후 시간외 거래에서 2.77% 하락한 304.99달러를 기록했다.
다음 읽기: <a href="https://www.benzinga.com/quote/SAM/analyst-ratings">보스턴 비어 컴퍼니에 대한 분석가 평가</a>
사진: 셔터스톡

골드만삭스(Goldman Sachs)의 분석가 본니 헤르조그(Bonnie Herzog)는 최근 베버리지 바이트(Beverage Bytes)의 설문조사에서 맥주 유통업체들로부터 얻은 피드백을 바탕으로 몰슨 쿠어스 베버리지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>)와 콘스텔레이션 브랜드(Constellation Brands Inc) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>)에 대한 판단을 좀 더 긍정적이고, 보스톤 비어 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>)에 대한 판단을 부정적으로 바꿨다.
이 분석가는 몰슨 쿠어스 베버리지의 주식평가를 <a href="https://www.benzinga.com/quote/TAP/analyst-ratings" target="_blank" rel="noreferrer noopener">중립 에서 매수로</a> 상향 조정했으며, 목표 주가도 66달러에서 75달러로 상향 조정했다.
헤르조그는 유통업체들이 TAP가 봄 선반 재설정의 큰 승자가 될 것으로 예상하고, 평균적으로 한 자릿수 중반의 선반 공간 비율을 점진적으로 확보할 것으로 기대한다는 점을 고려하면 긍정적인 위험/보상을 본다.
더 많은 유통업체들이 밀러 라이트(Miller Lite) 및 쿠어스 라이트(Coors Light)의 점유율 강화를 보고 있으며, 거의 80%의 유통업체들가 해당 브랜드가 점유율을 유지할 것으로 기대하고 있다고 그가 말했다.
이 분석가는 유통업체들의 78%가 3월에 TAP 브랜드의 재고를 더 많이 보유하고 있었으며 이는 TAP가 봄 재설정을 앞두고 1분기에 예상보다 더 많이 출하했을 수 있음을 시사한다.
그는 미주 지역의 출하량/고갈 성장에 대한 개선된 전망을 반영하여 TAP의 1분기 실적이 양호한 것으로 예상하고 있다.
이 분석가는 TAP의 시장 점유율 순풍이 현재 시장이 평가하는 것보다 더 지속 가능하다는 것이 입증됨에 따라 주식이 더 높게 재평가될 것으로 예상한다.
이 분석가는 콘스텔레이션 브랜드 주식에 대해 4월 11일에 발표될 4분기 실적을 앞두고 290달러의 목표주가와 <a href="https://www.benzinga.com/quote/STZ/analyst-ratings" target="_blank" rel="noreferrer noopener">매수 평가</a>를 재확인했다.
그는 STZ의 맥주 거래량 트렌드가 견고하며, 이번 봄에 추가로 선반과 쿨러 공간을 확보하는 데 가장 큰 수혜자가 될 것으로 예상되기 때문에 잠재적인 매출과 순익 선점이 가능할 것으로 보고 있다.
이 분석가의 긍정적인 견해는 강력한 소비자 수요, 유리한 인구 통계적 트렌드, 강력하고 명확한 브랜드 포지셔닝으로 인해 모델로(Modelo)에 대한 장기적인 성장 여정을 지지한다.
그는 STZ의 강력한 혁신으로 인해 역사적으로 30%였던 생산량 증가율이 향후 5년 동안 최대 40%까지 증가할 것으로 예상한다.
이 분석가는 모델로가 이끄는 핵심 맥주 브랜드를 통해 매력적인 성장을 이룰 수 있을 만큼 STZ의 사업에서 충분한 모멘텀을 계속해서 확인하고 있다. STZ는 그가 선호하는 최고의 주식 중 하나이다.
그는 보스톤 비어의 주식에 대한 평가를 <a href="https://www.benzinga.com/quote/SAM/analyst-ratings" target="_blank" rel="noreferrer noopener">매도로</a> 재확인했으며, 목표 주가는 257달러에서 250달러로 하향 조정했다.
이 분석가에 따르면 유통업체들은 새로운 경쟁업체들이 하드 티(hard tea) 카테고리에 넘쳐나면서 지난 몇 달 동안 트위스티드 티(Twisted Tea)의 모멘텀이 둔화되기 시작했다고 보고했다.
트위스티드 티(Twisted Tea)에 대한 낙관적인 전망에도 불구하고, 트위스티드 티가 트룰리(Truly)의 손실을 상쇄할 만큼 충분한 가치가 있는지에 대한 불확실성을 고려할 때, SAM의 리스크보상은 여전히 부정적인 쪽으로 기울어져 있다는 점을 이 분석가는 지적했다.
그는 유통사들이 SAM 제품의 재고를 계속해서 줄이고 있으며 봄 초기화 기간 동안 선반/쿨러 공간을 더 적게 할당할 것으로 기대한다.
따라서 이 분석가는 1분기의 회계연도 24/24/25년간의 주당 순이익 예측치를 각각 -$0.28/-$0.58/-$0.46, 즉 $0.11/$9.72/$12.63으로 하향 조정했다.
그는 지속적인 톱라인 턴어라운드 스토리의 징후가 더 많이 나타날 때까지 단기적으로 주식에 대한 부정적인 위험/보상이 더 많다고 본다.
주가 움직임: 화요일, SAM 주식은 1.92% 하락한 291.31달러에 마감했다.
사진 제공: 셔터스톡

Boston Beer Co

뉴스

에 대한 최신 뉴스 Boston Beer Co (NYSE:SAM) 주식

토요일, 6월 01, 2024

수요일, 4월 10, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌